Bharati R Dhruva

Array ( [id] => 7206831 [patent_doc_number] => 20040087537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Compositions comprising fusion polypeptides HIV-Nef and NGF, and methods of using the same' [patent_app_type] => new [patent_app_number] => 10/651836 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16821 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087537.pdf [firstpage_image] =>[orig_patent_app_number] => 10651836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382623 [patent_doc_number] => 20040082031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Inflammatory inhibition factor fwa116' [patent_app_type] => new [patent_app_number] => 10/469625 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082031.pdf [firstpage_image] =>[orig_patent_app_number] => 10469625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385929 [patent_doc_number] => 20040082533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Electro-gene therapy of arthritis by using an expression plasmid encoding the soluble p75 tumor necrosis factor receptor-Fc fusion protein' [patent_app_type] => new [patent_app_number] => 10/637864 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6118 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082533.pdf [firstpage_image] =>[orig_patent_app_number] => 10637864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216203 [patent_doc_number] => 20040071677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Nephritis treatment by gene therapy' [patent_app_type] => new [patent_app_number] => 10/634408 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11774 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071677.pdf [firstpage_image] =>[orig_patent_app_number] => 10634408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7356314 [patent_doc_number] => 20040013719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules' [patent_app_type] => new [patent_app_number] => 10/398449 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7876 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013719.pdf [firstpage_image] =>[orig_patent_app_number] => 10398449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347867 [patent_doc_number] => 20040248141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Spliceosome mediated RNA trans-splicing for correction of skin disorders' [patent_app_type] => new [patent_app_number] => 10/621867 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 17718 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248141.pdf [firstpage_image] =>[orig_patent_app_number] => 10621867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369519 [patent_doc_number] => 20040016009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Method of obtaining a non-human mammal susceptible to adenovirus-mediated gene delivery, a method for such delivery, and a non-human mammal susceptible to such delivery' [patent_app_type] => new [patent_app_number] => 10/363973 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4520 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20040016009.pdf [firstpage_image] =>[orig_patent_app_number] => 10363973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385926 [patent_doc_number] => 20040082532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Antifungal therapeutic targets' [patent_app_type] => new [patent_app_number] => 10/620149 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3769 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082532.pdf [firstpage_image] =>[orig_patent_app_number] => 10620149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199246 [patent_doc_number] => 20040086486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Method of enhancing delivery of a therapeutic nucleic acid' [patent_app_type] => new [patent_app_number] => 10/618299 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10037 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086486.pdf [firstpage_image] =>[orig_patent_app_number] => 10618299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405819 [patent_doc_number] => 20040105882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Medicament comprising HGF gene' [patent_app_type] => new [patent_app_number] => 10/615262 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7249 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20040105882.pdf [firstpage_image] =>[orig_patent_app_number] => 10615262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361730 [patent_doc_number] => 20040091464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Isolated stromal cells for use in the treatment of diseases of the central nervous system' [patent_app_type] => new [patent_app_number] => 10/608997 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19640 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091464.pdf [firstpage_image] =>[orig_patent_app_number] => 10608997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169253 [patent_doc_number] => 20040077610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Medicament containing a polyamine as an active substance' [patent_app_type] => new [patent_app_number] => 10/250511 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9135 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077610.pdf [firstpage_image] =>[orig_patent_app_number] => 10250511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7673350 [patent_doc_number] => 20040180429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Spliceosome mediated RNA trans-splicing in stem cells' [patent_app_type] => new [patent_app_number] => 10/456273 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10263 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180429.pdf [firstpage_image] =>[orig_patent_app_number] => 10456273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351402 [patent_doc_number] => 20040248826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Treatment of cancer by in vivo gene-transfer induced TIMP-3 expression' [patent_app_type] => new [patent_app_number] => 10/452878 [patent_app_country] => US [patent_app_date] => 2003-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24626 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248826.pdf [firstpage_image] =>[orig_patent_app_number] => 10452878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363913 [patent_doc_number] => 20040005550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Methods and compositions useful for targeting activated vitronectin receptor alphavbeta3' [patent_app_type] => new [patent_app_number] => 10/454660 [patent_app_country] => US [patent_app_date] => 2003-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9408 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005550.pdf [firstpage_image] =>[orig_patent_app_number] => 10454660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7134961 [patent_doc_number] => 20040043486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Methods and compositions for use in homologous recombination' [patent_app_type] => new [patent_app_number] => 10/446635 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12711 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043486.pdf [firstpage_image] =>[orig_patent_app_number] => 10446635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830355 [patent_doc_number] => 20030181413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Raf protein kinase therapeutics' [patent_app_type] => new [patent_app_number] => 10/440341 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 6286 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181413.pdf [firstpage_image] =>[orig_patent_app_number] => 10440341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851036 [patent_doc_number] => 20060234227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes' [patent_app_type] => utility [patent_app_number] => 10/514342 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 18108 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234227.pdf [firstpage_image] =>[orig_patent_app_number] => 10514342 [rel_patent_id] =>[rel_patent_doc_number] =>)